Follow-On Biologics, Drug Importation Get Split Decision From Bush Administration
This article was originally published in The Pink Sheet Daily
Executive Summary
Memo on potential amendments to FDA Revitalization Act threatens veto if importation provisions are attached and expresses concern about a generic biologic pathway but does not declare it unacceptable.